Thema
COVID-19 treatment
123
Journal Article
123
610
111
Study Type: Interventional
110
Phase: Phase 2
82
Recruitment Status: Authorised-recruitment may be ongoing or finished
62
SARS-CoV-2
53
COVID-19
50
Review
43
Recruitment Status: Not yet recruiting
41
Antiviral Agents
27
covid-19 treatment
22
Medical Condition: Coronavirus Disease 2019 (COVID-19) MedDRA version: 23.1Level: PTClassification code 10084460Term: COVID-19 treatmentSystem Organ Class: 10042613 - Surgical and medical procedures;Therapeutic area: Diseases [C] - Virus Diseases [C02]
18
Medical Condition: SARS-CoV-2 Infection MedDRA version: 23.1Level: PTClassification code 10084460Term: COVID-19 treatmentSystem Organ Class: 10042613 - Surgical and medical procedures;Therapeutic area: Diseases [C] - Virus Diseases [C02]
18
Phase: Phase 3
18
Medicine
15
R
15
COVID-19 treatments
14
Research Support, Non-U.S. Gov't
14
Medicine (General)
11
covid-19
11
remdesivir
11
4QWG6N8QKH
10
Hydroxychloroquine
10
Medical Condition: Moderate to severe coronavirus disease 2019 (COVID 19) MedDRA version: 23.1Level: LLTClassification code 10084401Term: COVID-19 respiratory infectionSystem Organ Class: 100000004862 MedDRA version: 23.1Level: PTClassification code 10084460Term: COVID-19 treatmentSystem Organ Class: 10042613 - Surgical and medical procedures MedDRA version: 23.0Level: LLTClassification code 10084382Term: Coronavirus disease 2019System Organ Class: 100000004862 MedDRA version: 23.1Level: LLTClassification code 10084529Term: 2019 novel coronavirus infectionSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]
10
hydroxychloroquine
10
Coronavirus
9
sars-cov-2
8
clinical trials
7
Chronic kidney disease
6
Covid-19 treatment
6
Medical Condition: Subjects infected with SARS-CoV-2, admitted to the hospital due to COVID-19. MedDRA version: 23.1Level: PTClassification code 10084460Term: COVID-19 treatmentSystem Organ Class: 10042613 - Surgical and medical procedures MedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
6
Recruitment Status: Recruiting
6
Therapeutics. Pharmacology
6
monoclonal antibodies
6
3QKI37EEHE
5
7S5I7G3JQL
5
Anti-Inflammatory Agents
5
Antiviral therapy
5
COVID-19 Treatment
5
Case Reports
5
Dexamethasone
5
Randomized Controlled Trial
5
Remdesivir
5
3,6-Dichloropyrazine-2-carbonitrile
4
415SHH325A
4
Access to COVID-19 treatment
4
Access to medicines
4
Active Pharmaceutical Ingredient (API) synthesis
4
Adenosine Monophosphate
4
mehr ...